We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
(+0.84%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$56.7M |
| 2 |
Apollo Global Management
APO
|
+$36.8M |
| 3 |
Boeing
BA
|
+$34.1M |
| 4 |
Workday
WDAY
|
+$31.9M |
| 5 |
DOCU
DocuSign
DOCU
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$84.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$48.4M |
| 5 |
XYZ
Block Inc
XYZ
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.97% |
| 2 | Financials | 13.53% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Healthcare | 10.06% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
OptimizeRx
OPRX
$133M
| $122K | ﹤0.01% |
25,149
+1,249
| +5% | +$6.98K |
|
|
CTNM
3152
Contineum Therapeutics
CTNM
$566M
| $121K | ﹤0.01% |
8,233
+2,191
| +36% | +$34.7K |
|
3153
OppFi
OPFI
$803M
| $120K | ﹤0.01% |
15,700
-28
| -0.2% | -$177 |
|
3154
Black Diamond Therapeutics
BDTX
$112M
| $120K | ﹤0.01% |
56,135
+7,290
| +15% | +$20.9K |
|
3155
Traeger
COOK
$172M
| $120K | ﹤0.01% |
1,005
+25
| +3% | +$3.83K |
|
|
GCTS
3156
GCT Semiconductor Holding
GCTS
$235M
| $120K | ﹤0.01% |
51,327
+45,612
| +798% | +$115K |
|
|
MPX
3157
DELISTED
Marine Products Corp
MPX
| $118K | ﹤0.01% |
12,923
+1,236
| +11% | +$11.9K |
|
|
BLUE
3158
DELISTED
bluebird bio
BLUE
| $118K | ﹤0.01% |
14,176
+621
| +5% | +$5.43K |
|
3159
InnovAge Holding
INNV
$1.52B
| $118K | ﹤0.01% |
29,994
-25
| -0.1% | -$129 |
|
|
CBD
3160
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $118K | ﹤0.01% |
363,195
| – | – |
|
3161
Puma Biotechnology
PBYI
$454M
| $117K | ﹤0.01% |
38,291
-8,337
| -18% | -$24.3K |
|
|
FINV
3162
FinVolution Group
FINV
$1.15B
| $116K | ﹤0.01% |
17,156
-24
| -0.1% | -$154 |
|
3163
Tenaya Therapeutics
TNYA
$163M
| $115K | ﹤0.01% |
80,686
+1,087
| +1% | +$2.44K |
|
3164
Atossa Therapeutics
ATOS
$23.5M
| $115K | ﹤0.01% |
8,148
-55
| -0.7% | -$1.07K |
|
3165
NLI Holdings
NL
$317M
| $115K | ﹤0.01% |
14,816
+2,217
| +18% | +$17.5K |
|
|
APLT
3166
DELISTED
Applied Therapeutics
APLT
| $115K | ﹤0.01% |
134,335
+988
| +0.7% | +$6.19K |
|
|
CD
3167
Chaince Digital Holdings
CD
$211M
| $114K | ﹤0.01% |
16,654
+25
| +0.2% | +$97 |
|
3168
Lexicon Pharmaceuticals
LXRX
$1.1B
| $113K | ﹤0.01% |
153,151
+7,212
| +5% | +$8.69K |
|
|
UHG
3169
DELISTED
United Homes Group
UHG
| $112K | ﹤0.01% |
26,596
+21,597
| +432% | +$120K |
|
|
B
3170
Barrick Mining
B
$73.2B
| $112K | ﹤0.01% |
7,256
+362
| +5% | +$6.58K |
|
|
SUNS
3171
Sunrise Realty Trust
SUNS
$105M
| $112K | ﹤0.01% |
7,986
+75
| +0.9% | +$1.08K |
|
3172
HUTCHMED
HCM
$2.17B
| $112K | ﹤0.01% |
7,799
+90
| +1% | +$1.61K |
|
3173
Tilly's
TLYS
$128M
| $110K | ﹤0.01% |
25,988
+100
| +0.4% | +$408 |
|
|
VCSA
3174
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $110K | ﹤0.01% |
22,372
-7,544
| -25% | -$24.2K |
|
3175
Nerdy
NRDY
$96.7M
| $110K | ﹤0.01% |
67,643
-4,101
| -6% | -$5.09K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2024 Portfolio in Review
As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
- RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
- RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
- RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
- RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
- RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.
Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.